Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B.
Kirino S, Tamaki N, Kurosaki M, Kaneko S, Inada K, Tanaka Y, Ishido S, Yamashita K, Nobusawa T, Matsumoto H, Hayakawa Y, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N.
Kirino S, et al. Among authors: kakegawa t.
Hepatol Res. 2023 Jan;53(1):35-42. doi: 10.1111/hepr.13839. Epub 2022 Oct 4.
Hepatol Res. 2023.
PMID: 36117296